128 related articles for article (PubMed ID: 36725694)
41. Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model.
Dahlgren D; Roos C; Peters K; Lundqvist A; Tannergren C; Sjögren E; Sjöblom M; Lennernäs H
Eur J Pharm Biopharm; 2019 Sep; 142():31-37. PubMed ID: 31201856
[TBL] [Abstract][Full Text] [Related]
42. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
43. Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition.
Bedada SK; Yellu NR; Neerati P
Pharmacol Rep; 2016 Apr; 68(2):338-43. PubMed ID: 26922536
[TBL] [Abstract][Full Text] [Related]
44. Absorption Properties of Luteolin and Apigenin in Genkwa Flos Using In Situ Single-Pass Intestinal Perfusion System in the Rat.
He X; Song ZJ; Jiang CP; Zhang CF
Am J Chin Med; 2017; 45(8):1745-1759. PubMed ID: 29121796
[TBL] [Abstract][Full Text] [Related]
45. Visualized absorption of anti-atherosclerotic dipeptide, Trp-His, in Sprague-Dawley rats by LC-MS and MALDI-MS imaging analyses.
Tanaka M; Hong SM; Akiyama S; Hu QQ; Matsui T
Mol Nutr Food Res; 2015 Aug; 59(8):1541-9. PubMed ID: 25808120
[TBL] [Abstract][Full Text] [Related]
46. Investigation of the effect of concurrently administered carvedilol, atorvastatin and bile salts on intestinal absorption of linagliptin.
Embaby MA; El Maghraby GM; Osman MA; Sultan AA
J Pharm Pharmacol; 2023 Apr; 75(5):635-644. PubMed ID: 36856806
[TBL] [Abstract][Full Text] [Related]
47. In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay.
Rabba AK; Si L; Xue K; Li M; Li G
J Pharm Pharm Sci; 2011; 14(2):138-47. PubMed ID: 21733405
[TBL] [Abstract][Full Text] [Related]
48. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
49. Herb-drug interactions: Quantitative analysis of levofloxacin absorption and transporter expression in the rat intestine following combined treatment with Persicaria capitata (Buch.-Ham. ex D. Don) H. Gross.
Zhou Y; Chi M; Zhou Z; Wang L; Yuan L; Zheng L; Huang Y
J Pharm Biomed Anal; 2024 Aug; 245():116156. PubMed ID: 38636190
[TBL] [Abstract][Full Text] [Related]
50. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
51. [In situ rats single pass perfusion intestinal absorption of the effectivein components in Radix Angelicae Pubescentis].
Wu YN; Luan LB
Yao Xue Xue Bao; 2008 Jan; 43(1):102-7. PubMed ID: 18357742
[TBL] [Abstract][Full Text] [Related]
52. Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion.
Lozoya-Agullo I; Zur M; Beig A; Fine N; Cohen Y; González-Álvarez M; Merino-Sanjuán M; González-Álvarez I; Bermejo M; Dahan A
Int J Pharm; 2016 Dec; 515(1-2):201-208. PubMed ID: 27667756
[TBL] [Abstract][Full Text] [Related]
53. [Validation of in situ single pass perfusion model based on P-gp].
Dong YL; Liu Y; Yin XW; Pan M; Li XL; Wang ZY; Dong L
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1539-1544. PubMed ID: 29071859
[TBL] [Abstract][Full Text] [Related]
54. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice.
Miyake T; Tsutsui H; Haraya K; Tachibana T; Morimoto K; Takehara S; Ayabe M; Kobayashi K; Kazuki Y
Br J Pharmacol; 2021 Nov; 178(21):4335-4351. PubMed ID: 34232502
[TBL] [Abstract][Full Text] [Related]
55. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.
Okyar A; Dressler C; Hanafy A; Baktir G; Lemmer B; Spahn-Langguth H
Chronobiol Int; 2012 May; 29(4):443-53. PubMed ID: 22489638
[TBL] [Abstract][Full Text] [Related]
56. Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat.
Cook TJ; Shenoy SS
Toxicology; 2003 Mar; 184(2-3):125-33. PubMed ID: 12499115
[TBL] [Abstract][Full Text] [Related]
57. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
[TBL] [Abstract][Full Text] [Related]
58. Intestinal absorption of pallidifloside D are limited by P-glycoprotein in mice.
Wang MY; Yang M; Hou PY; Chen XB; Li HG; Yan JX; Zhang J; Zhang YW; Wu XH
Xenobiotica; 2018 Jul; 48(7):739-744. PubMed ID: 28707509
[TBL] [Abstract][Full Text] [Related]
59. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
60. [Applicability analysis and evaluation of aglycones in single-pass intestinal perfusion technique based on PBPK model].
Liu Y; Zhang X; Shi XJ; Wen YX; Yang L; Dong L
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3645-3652. PubMed ID: 31602936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
